Call 1-877-649-3867 to Enroll Today!
Patient Assistance
For Meeting Your Patient’s Needs
Nobelpharma Connect strives to deliver personalized services and support for patients and their Healthcare Providers.
Personalized Services and Support
At Nobelpharma America, we understand that navigating healthcare can be overwhelming, especially for patients facing unique challenges. Our Nobelpharma Connect program dedicated team is committed to bridging the gap between patients and access to innovative treatments like HYFTOR®, ensuring that every eligible patient receives the personalized care they deserve. Through tailored support programs, we empower healthcare providers to guide their patients through the complexities of treatment access, fostering a collaborative environment where every patient feels valued and supported on their journey towards improved health.
Start Today Without Delay for Your Patients!
Access to Therapy
Nobelpharma America’s Bridge Program aids eligible patients who have an existing prescription but may experience a temporary lapse in insurance.
Our Quick Start Program to help patients during coverage delays, limited supply at no cost to new eligible patients who experience a delay in insurance coverage.
In addition, the Nobelpharma America Patient Assistance Program can help cover costs for eligible patients with a prescription who may not have insurance coverage.
You are now leaving the HYFTOR® healthcare professionals website. This link will take you to Nobelpharma Connect website.
Indication and Important Safety Information
Indication HYFTOR® is an mTOR inhibitor immunosuppressant indicated for the treatment of facial angiofibroma associated with tuberous sclerosis in adults and pediatric patients 6 years of age and older.
Important Safety Information
Contraindications HYFTOR® is contraindicated in patients with a history of hypersensitivity to sirolimus or any other component of HYFTOR®.